The Mechanism of Action of the Anti-Cd38 Monoclonal Antibody Isatuximab in Multiple Myeloma
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-18-1597
Full Text
Open PDFAbstract
Available in full text
Date
January 28, 2019
Authors
Publisher
American Association for Cancer Research (AACR)